Latest Equity Raises News

Paladin Energy reported a stronger half-year performance with US$138.3 million revenue from uranium sales, a narrowed net loss, and a successful A$400 million equity raise to fund growth projects.

Paladin Energy reported a strong half-year performance with uranium sales revenue climbing to US$138.3 million, driven by ramp-up at its Namibian mine and significant progress on Canadian development projects.

Origin Energy reported robust half-year results for December 2025, driven by strong Energy Markets performance and significant customer growth, while updating FY26 guidance with higher earnings expectations.

Tamboran Resources Corporation reported a 26% reduction in half-year losses as it progresses key natural gas projects in Australia’s Beetaloo Basin and prepares for a major acquisition of Falcon Oil & Gas Ltd.

Origin Energy reports a 45% drop in half-year profit amid lower gas earnings and ongoing investments, while extending Eraring Power Station operations to 2029 to support NSW energy security.

PYC Therapeutics has initiated a substantial capital raising effort, aiming to secure up to A$653 million to propel its four RNA therapeutic candidates through critical clinical milestones. The retail entitlement offer opens today, following a successful institutional placement.

Challenger Limited confirms advanced discussions with Pepper Group to jointly acquire Pepper Money, aiming for strategic access to fixed income assets and accretive earnings.

Canyon Resources updates progress on its Minim Martap Bauxite Project, confirming key milestones despite locomotive delivery delays that push the maiden bauxite shipment to Q3 2026.

Terragen Holdings has raised A$7 million through a strategic equity raising to fund scientific research and accelerate global commercialisation, while appointing Dr Michele Allan AO as its new Chair.

HMC Capital has forged a strategic partnership with global investor KKR, securing up to $603 million to expand its Energy Transition Platform focused on battery storage and wind projects. This deal aims to boost Australia’s renewable capacity while enhancing shareholder returns.

Lotus Resources has launched a A$81 million equity raising to support the ramp-up of its Kayelekera uranium mine to steady state production targeted in Q2 2026, while advancing development of its Letlhakane project.

Cyclopharm Limited is accelerating its US market push for Technegas with a A$16 million capital raise following a record 2025 sales performance. The company aims to expand its US installations and advance new clinical applications beyond pulmonary embolism.